Mass prostate cancer screenings don’t reduce death
A new study shows that annual prostate cancer screening does not reduce deaths from the disease, even among men in their 50s and 60s and those with underlying health conditions.
The study was published online Jan. 6 in the Journal of the National Cancer Institute.
Recommendation against PSA test goes too far
A draft recommendation by the U.S. Preventive Services Task Force calling for an end to routine PSA testing for healthy men age 50 and older goes too far, says Gerald Andriole, MD, a prostate cancer expert at Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis.